Medico Remedies Ltd - 540937 - Shareholding for the Period Ended March 31, 2021
Medico Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here20-04-2021
Medico Remedies Ltd - 540937 - Shareholding for the Period Ended March 31, 2021
Medico Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click hereMedico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended March 2021 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Haresh MehtaDesignation :- Managing Director / Whole Time DirectorMedico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Haresh MehtaDesignation :- Managing Director / Whole Time DirectorMedico Remedies Ltd - 540937 - Compliance Certificate For The Half Year Ended 31St March, 2021
Compliance Certificate for the half year ended 31st March, 2021Medico Remedies Ltd - 540937 - Closure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended & Company''s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in its securities, the ''Trading Window'' for dealing in the equity shares of the Company is closed, for all Insiders, Designated Persons and their immediate relatives, from 1st April, 2021 up to the expiry of 48 hours post the date of declaration of the Audited Financial Results for the year ended March 31st , 2021Medico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- HARESH MEHTADesignation :- Chief Financial OfficerMedico Remedies Ltd - 540937 - Unaudited Financial Results Of The Company For The Half Year Ended 30Th September, 2020 Along With The Limited Review Report Thereon
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 12th November, 2020 has, inter alia considered and approved the Unaudited Financial Results of the Company for the half year ended 30th September, 2020 along with the Limited Review Report thereonMedico Remedies Ltd - 540937 - Unaudited Financial Results Of The Company For The Half Year Ended 30Th September, 2020 Along With The Limited Review Report Thereon
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 12th November, 2020 has, inter alia considered and approved the Unaudited Financial Results of the Company for the half year ended 30th September, 2020 along with the Limited Review Report thereonMedico Remedies Ltd - 540937 - Board Meeting Intimation for To Consider And Approve, The Unaudited Financial Results For The Half Year Ended September 30, 2020 Along With The Limited Review Report Thereon
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve the Unaudited Financial Results for the Half year ended September 30, 2020 along with the Limited Review Report thereon